Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Immunovant, Inc.
IMVT
Segment Reporting Other Item Amount
Segment Reporting Other Item Amount at other companies
Essential Utilities
WTRG
-$75K
+74.4%
Protagonist Therapeutics
PTGX
-$53K
+35.4%
Corvex
MOVE
$1.42M
—
ConocoPhillips
COP
$7.22B
+6.1%
SiTime Corporation
SITM
$71.86M
+26.2%
Atmos Energy
ATO
$1.01B
-7.3%
Segments
By segment
See full
Reportable Segment
-$3.64M
—
Other financials
Income statement
See full
Net income
-$147.9M
-38.9%
EPS (diluted)
-$0.73
-15.9%
Balance sheet
See full
Cash & equivalents
$902.1M
+26.4%
Total debt
$72.0K
-26.5%
Total equity
$852.6M
+20.5%
Total assets
$957.0M
+23.3%
Cash flow
See full
Operating cash flow
-$95.1M
+14.1%
CapEx
$8.0K
-96.0%
Free cash flow
-$95.1M
+14.2%
Valuation
See full
Market cap
$7.26B
+74.2%
Enterprise value
$6.35B
+89.7%
Returns & leverage
See full
Return on equity
-64.8%
+2.5pp
Debt / equity
0×
0.0×
Current ratio
9.1×
-2.1×